Barriers to Follow-up Colonoscopies for Patients With Positive Results From Fecal Immunochemical Tests During Colorectal Cancer Screening

Clinical Gastroenterology and Hepatology

Volumn 17, Issue 3, 2019, Pages 469-476

  May, Folasade P ^a,b,c   Yano, Elizabeth M ^c,d   Provenzale, Dawn ^f,g   Brunner, Julian ^c,d   Yu, Christine ^b   Phan, Jennifer ^b   Bharath, Purnima ^a,c   Aby, Elizabeth ^b   Dinh, Doantrang ^b   Ehrlich, Dean S ^b   Storage, Tina R ^b   Lin, Lisa D ^b   Jamaluddin, Nimah N ^b   Washington, Donna L ^a,c,e  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Colon Cancer; Epidemiology; Prevention; Quality

Indexed keywords

ADENOMATOUS POLYP; ADULT; ADVANCED CANCER; AGED; ARTICLE; CALIFORNIA; CANCER SCREENING; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOCTOR PATIENT RELATIONSHIP; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SCHEDULING; RETROSPECTIVE STUDY; TREATMENT RESPONSE TIME; VETERAN; CHEMISTRY; COLORECTAL TUMOR; DIAGNOSTIC TEST; EARLY CANCER DIAGNOSIS; FECES; MIDDLE AGED; PROCEDURES;

AGED; CALIFORNIA; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TESTS, ROUTINE; EARLY DETECTION OF CANCER; FACILITIES AND SERVICES UTILIZATION; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VETERANS;

EID: 85060272040     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2018.05.022     Document Type: Article

References (19)

1. Ransohoff, D.F., Sox, H.C., Clinical practice guidelines for colorectal cancer screening: new recommendations and new challenges. JAMA 315 (2016), 2529–2531.
2. Rex, D.K., Boland, C.R., Dominitz, J.A., et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology 153 (2017), 307–323.
3. Corley, D.A., Jensen, C.D., Quinn, V.P., et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA 317 (2017), 1631–1641.
4. Lee, Y.C., Li-Sheng Chen, S., Ming-Fang Yen, A., et al. Association between colorectal cancer mortality and gradient fecal hemoglobin concentration in colonoscopy noncompliers. J Natl Cancer Inst, 109, 2017, 5.
5. Robertson, D.J., Lee, J.K., Boland, C.R., et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 112 (2017), 37–53.
6. Issaka, R.B., Singh, M.H., Oshima, S.M., et al. Inadequate utilization of diagnostic colonoscopy following abnormal FIT results in an integrated safety-net system. Am J Gastroenterol 112 (2017), 375–382.
7. Rao, S.K., Schilling, T.F., Sequist, T.D., Challenges in the management of positive fecal occult blood tests. J Gen Intern Med 24 (2009), 356–360.
8. Carlson, C.M., Kirby, K.A., Casadei, M.A., et al. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?. Arch Intern Med 171 (2011), 249–256.
9. Partin, M.R., Gravely, A.A., Burgess, J.F. Jr., et al. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results. Cancer 123 (2017), 3502–3512.
10. Deyo, R.A., Cherkin, D.C., Ciol, M.A., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992), 613–619.
11. McCarthy, A.M., Kim, J.J., Beaber, E.F., et al. Follow-up of abnormal breast and colorectal cancer screening by race/ethnicity. Am J Prev Med 51 (2016), 507–512.
12. Zapka, J., Taplin, S.H., Price, R.A., et al. Factors in quality care–the case of follow-up to abnormal cancer screening tests–problems in the steps and interfaces of care. J Natl Cancer Inst Monogr 2010 (2010), 58–71.
13. Oluloro, A., Petrik, A.F., Turner, A., et al. Timeliness of colonoscopy after abnormal fecal test results in a safety net practice. J Community Health 41 (2016), 864–870.
14. Martin, J., Halm, E.A., Tiro, J.A., et al. Reasons for lack of diagnostic colonoscopy after positive result on fecal immunochemical test in a safety-net health system. Am J Med 130 (2017), 93e1–93e7.
15. Jimbo, M., Myers, R.E., Meyer, B., et al. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med 7 (2009), 11–16.
16. Gupta, S., Nodora, J., Optimizing the quality of the colorectal cancer screening continuum: a call to action. J Natl Cancer Inst, 109, 2017, 5.
17. Chubak, J., Garcia, M.P., Burnett-Hartman, A.N., et al. Time to colonoscopy after positive fecal blood test in four U.S. health care systems. Cancer Epidemiol Biomarkers Prev 25 (2016), 344–350.
18. Crotta, S., Segnan, N., Paganin, S., et al. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol 10 (2012), 633–638.
19. Thamarasseril, S., Bhuket, T., Chan, C., et al. The need for an integrated patient navigation pathway to improve access to colonoscopy after positive fecal immunochemical testing: a safety-net hospital experience. J Community Health 42 (2017), 551–557.